BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹22 Cr | ₹2.31 Cr | ₹2.83 Cr | ₹0.57 Cr | - |
What is the latest Capital Work in Progress ratio of BALAXI PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹2.31 Cr |
| Mar2023 | ₹2.83 Cr |
| Mar2022 | ₹0.57 Cr |
| Mar2021 | - |
How is Capital Work in Progress of BALAXI PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | 856.28 | |
| Mar2024 | ₹2.31 Cr | -18.50 | |
| Mar2023 | ₹2.83 Cr | 395.10 | |
| Mar2022 | ₹0.57 Cr | 0 | |
| Mar2021 | - | - | |
Compare Capital Work in Progress of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹147.3 Cr | -3% | 50.4% | -56% | Stock Analytics | |
| ADANI ENTERPRISES | ₹315,622.0 Cr | 5.4% | 28.6% | 1.9% | Stock Analytics | |
| REDINGTON | ₹16,761.2 Cr | -2.9% | 1.5% | -12.3% | Stock Analytics | |
| HONASA CONSUMER | ₹11,262.7 Cr | 0.1% | 17.8% | 45.7% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹10,551.5 Cr | 3% | 55.5% | 41.8% | Stock Analytics | |
| MMTC | ₹9,826.5 Cr | -2.2% | 15% | 6.8% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -3% |
50.4% |
-56% |
| SENSEX | -1.3% |
4.6% |
-3.3% |
You may also like the below Video Courses